Tech Company Financing Transactions
Mithridion Funding Round
Mithridion closed a $2.9 million Series B funding round on 1/12/2009. Investors included Rocket Ventures, Venture Investors and Wisconsin Investment Partners.
Transaction Overview
Company Name
Announced On
1/12/2009
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Series B
Investors
Proceeds Purpose
The company will use the funds for the clinical development of MCD-386, its lead drug candidate, aimed at stopping or slowing down disease progression and improving memory and cognition in this devastating disorder.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
505 Science Drive C
Madison, WI 53511
USA
Madison, WI 53511
USA
Phone
Website
Email Address
Overview
Mithridion is a biopharmaceutical company that discovers and develops drugs for neurodegenerative diseases, with a focus on Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Trevor Twose
Browse more venture capital transactions:
Prev: 1/12/2009: DECA venture capital transaction
Next: 1/12/2009: Multiverse Network venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs